SEC Form 4 · accession 0001104659-26-073468
Orchestra BioMed Holdings, Inc. · OBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Hochman
Officer — See Remarks · Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001814114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share ("Common Stock") | Jun 10, 2026 | F | 3,283 | $4.02 | D | 1,060,746 | D | |
| Common Stock | Jun 10, 2026 | F | 3,283 | $4.02 | D | 436,199 | I | By the DPH 2008 Trust |
| Common Stock | holding | — | — | — | 2,000 | I | By the Solomon Ascher Hochman 2019 Trust | |
| Common Stock | holding | — | — | — | 2,000 | I | By the Hannah Hochman 2019 Trust | |
| Common Stock | holding | — | — | — | 2,000 | I | By the Judah Herman Hochman 2019 Trust | |
| Common Stock | holding | — | — | — | 3,140 | I | By the NSH 2008 Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
Remarks
Chief Executive Officer and Chairperson